485 related articles for article (PubMed ID: 8955576)
1. Assessment of the allergic reaction in seasonal rhinitis: acoustic rhinometry is a sensitive and objective method.
Nielsen LP; Bjerke T; Christensen MB; Pedersen B; Rasmussen TR; Dahl R
Clin Exp Allergy; 1996 Nov; 26(11):1268-75. PubMed ID: 8955576
[TBL] [Abstract][Full Text] [Related]
2. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
[TBL] [Abstract][Full Text] [Related]
3. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.
Oztürk F; Türktaş I; Asal K; Ileri F; Münevver Pinar N
Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):1007-15. PubMed ID: 15236886
[TBL] [Abstract][Full Text] [Related]
4. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
[TBL] [Abstract][Full Text] [Related]
5. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
7. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
[TBL] [Abstract][Full Text] [Related]
8. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
9. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
[TBL] [Abstract][Full Text] [Related]
11. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
Turner P; Dear J; Scadding G; Foreman JC
J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
[TBL] [Abstract][Full Text] [Related]
12. In vitro diagnosis of chronic nasal inflammation.
Kramer MF; Burow G; Pfrogner E; Rasp G
Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
[TBL] [Abstract][Full Text] [Related]
13. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
Klimek L; Rasp G
Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
[TBL] [Abstract][Full Text] [Related]
14. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of selected eosinophil activity parameters in children with hay fever].
Cichocka-Jarosz E; Lis G; Pietrzyk JJ
Przegl Lek; 1997; 54(9):607-13. PubMed ID: 9501680
[TBL] [Abstract][Full Text] [Related]
16. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
17. Induced sputum to assess airway inflammation: a study of reproducibility.
Spanevello A; Migliori GB; Sharara A; Ballardini L; Bridge P; Pisati P; Neri M; Ind PW
Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
[TBL] [Abstract][Full Text] [Related]
19. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
20. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
Kramer MF; Ostertag P; Pfrogner E; Rasp G
Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
